China Biologic Products Holdings, Inc.
CBPO
CBPO was delisted on the 20th of April, 2021.
109 hedge funds and large institutions have $1.9B invested in China Biologic Products Holdings, Inc. in 2015 Q2 according to their latest regulatory filings, with 42 funds opening new positions, 37 increasing their positions, 28 reducing their positions, and 10 closing their positions.
320% more first-time investments, than exits
New positions opened: 42 | Existing positions closed: 10
50% more funds holding in top 10
Funds holding in top 10: 4 → 6 (+2)
40% more funds holding
Funds holding: 78 → 109 (+31)
32% more capital invested
Capital invested by funds: $1.44B → $1.9B (+$465M)
32% more repeat investments, than reductions
Existing positions increased: 37 | Existing positions reduced: 28
16% more call options, than puts
Call options by funds: $18.8M | Put options by funds: $16.3M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Capital World Investors
Los Angeles,
California
|
+$107M |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$60.6M |
| 3 |
BG
BlackRock Group
London,
United Kingdom
|
+$24.9M |
| 4 |
Bank of New York Mellon
New York
|
+$19.9M |
| 5 |
KM
Kylin Management
New York
|
+$19.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
WP
Warburg Pincus
New York
|
-$278M |
| 2 |
LBA
Letko, Brosseau & Associates
Montreal,
Quebec, Canada
|
-$8.34M |
| 3 |
JP Morgan Chase
New York
|
-$3.59M |
| 4 |
Renaissance Technologies
New York
|
-$3.07M |
| 5 |
SIM
Spark Investment Management
New York
|
-$2.68M |
CBPO Hedge Fund Activity: Q2 2015 in Review
109 of the 3,730 institutional investors tracked by Wall St. Rank reported a position in China Biologic Products Holdings, Inc. (CBPO) for Q2 2015, worth a combined $1.9B — up 32% from $1.44B a quarter earlier.
Buyers outnumbered sellers: 42 funds opened new CBPO positions and 10 closed out — a net gain of 32 holders — while 37 added to existing stakes and 28 trimmed.
The largest buyer was Capital World Investors, opening a new position worth an estimated $107M. The largest seller was Warburg Pincus, cutting an estimated $278M.
- 109 institutional investors held China Biologic Products Holdings, Inc. (CBPO) as of Q2 2015, up from 78 in Q1 2015.
- Funds reported $1.9B of China Biologic Products Holdings, Inc. stock for Q2 2015, up 32% quarter-over-quarter.
- 42 funds opened new China Biologic Products Holdings, Inc. positions in Q2 2015 and 10 closed out, a net change of +32 holders.
- The largest China Biologic Products Holdings, Inc. buyer in Q2 2015 was Capital World Investors, an estimated $107M added.
- The largest China Biologic Products Holdings, Inc. seller in Q2 2015 was Warburg Pincus, an estimated $278M sold.
Based on aggregated 13F filings for Q2 2015.